Symbols / BBIO Stock $65.95 +1.96% BridgeBio Pharma, Inc.

Healthcare • Biotechnology • United States • NMS
BBIO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country NMS · United States
Market Cap 12.92B
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $64.68
Price $65.95
Change 1.96%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest BBIO news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
502.08
+126.26%
221.90
+2285.27%
9.30
-88.02%
77.65
Operating Revenue
502.08
+126.26%
221.90
+2285.27%
9.30
-88.02%
77.65
Cost Of Revenue
20.96
+440.54%
3.88
+58.54%
2.45
-28.77%
3.43
Reconciled Cost Of Revenue
20.96
+440.54%
3.88
+58.54%
2.45
-28.77%
3.43
Gross Profit
481.11
+120.67%
218.02
+3079.58%
6.86
-90.76%
74.21
Operating Expense
983.18
+23.61%
795.39
+31.19%
606.30
+11.73%
542.65
Research And Development
451.95
-10.76%
506.46
+11.14%
455.71
+14.08%
399.46
Selling General And Administration
531.23
+83.86%
288.93
+91.87%
150.59
+5.17%
143.19
Total Expenses
1,004.14
+25.63%
799.27
+31.30%
608.75
+11.47%
546.09
Operating Income
-502.06
+13.04%
-577.37
+3.68%
-599.44
-27.97%
-468.44
Total Operating Income As Reported
-523.41
+11.73%
-592.97
+2.37%
-607.37
-18.58%
-512.20
EBITDA
-548.83
-25.64%
-436.83
+22.75%
-565.47
-42.28%
-397.44
Normalized EBITDA
-506.33
+11.63%
-572.96
-2.76%
-557.54
-61.39%
-345.46
Reconciled Depreciation
5.43
-10.55%
6.08
-6.45%
6.49
-4.09%
6.77
EBIT
-554.26
-25.14%
-442.90
+22.56%
-571.96
-41.50%
-404.21
Total Unusual Items
-42.50
-131.22%
136.13
+1817.46%
-7.93
+84.75%
-51.99
Total Unusual Items Excluding Goodwill
-42.50
-131.22%
136.13
+1817.46%
-7.93
+84.75%
-51.99
Special Income Charges
-42.50
-131.22%
136.13
+1817.46%
-7.93
+81.89%
-43.77
Other Special Charges
21.16
-20.44%
26.59
—
—
Impairment Of Capital Assets
0.00
-100.00%
0.27
0.00
-100.00%
12.72
Restructuring And Mergern Acquisition
21.35
+39.21%
15.33
+93.46%
7.93
-74.47%
31.05
Write Off
—
—
7.21
-65.23%
20.74
Net Income
-724.93
-35.31%
-535.76
+16.70%
-643.20
-33.67%
-481.18
Pretax Income
-732.50
-35.10%
-542.19
+17.00%
-653.25
-34.79%
-484.65
Net Non Operating Interest Income Expense
-158.39
-93.06%
-82.04
-29.71%
-63.25
+13.23%
-72.90
Interest Expense Non Operating
178.24
+79.52%
99.29
+22.14%
81.29
+1.06%
80.44
Net Interest Income
-158.39
-93.06%
-82.04
-29.71%
-63.25
+13.23%
-72.90
Interest Expense
178.24
+79.52%
99.29
+22.14%
81.29
+1.06%
80.44
Interest Income Non Operating
19.85
+15.10%
17.25
-4.37%
18.04
+139.17%
7.54
Interest Income
19.85
+15.10%
17.25
-4.37%
18.04
+139.17%
7.54
Other Income Expense
-72.05
-161.47%
117.22
+1141.16%
9.44
-83.34%
56.68
Other Non Operating Income Expenses
43.06
+250.86%
12.27
-29.35%
17.37
-84.02%
108.67
Gain On Sale Of Security
—
8.14
-55.54%
18.30
+322.57%
-8.22
Gain On Sale Of Business
0.00
-100.00%
178.32
0.00
0.00
Tax Provision
0.43
-62.27%
1.15
0.00
0.00
Tax Rate For Calcs
0.00
+0.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
-8.93
-131.22%
28.59
0.00
0.00
Net Income Including Noncontrolling Interests
-732.94
-34.89%
-543.35
+16.82%
-653.25
-34.79%
-484.65
Net Income From Continuing Operation Net Minority Interest
-724.93
-35.31%
-535.76
+16.70%
-643.20
-33.67%
-481.18
Net Income From Continuing And Discontinued Operation
-724.93
-35.31%
-535.76
+16.70%
-643.20
-33.67%
-481.18
Net Income Continuous Operations
-732.94
-34.89%
-543.35
+16.82%
-653.25
-34.79%
-484.65
Minority Interests
8.01
+5.56%
7.58
-24.52%
10.05
+189.68%
3.47
Normalized Income
-691.35
-7.47%
-643.30
-1.26%
-635.28
-48.02%
-429.20
Net Income Common Stockholders
-724.93
-35.31%
-535.76
+16.70%
-643.20
-33.67%
-481.18
Diluted EPS
-3.78
-31.25%
-2.88
+27.09%
-3.95
-21.17%
-3.26
Basic EPS
-3.78
-31.25%
-2.88
+27.09%
-3.95
-21.17%
-3.26
Basic Average Shares
191.53
+2.93%
186.08
+14.30%
162.79
+10.39%
147.47
Diluted Average Shares
191.53
+2.93%
186.08
+14.30%
162.79
+10.39%
147.47
Diluted NI Availto Com Stockholders
-724.93
-35.31%
-535.76
+16.70%
-643.20
-33.67%
-481.18
Earnings From Equity Interest
-72.61
-132.84%
-31.18
0.00
0.00
Gain On Sale Of PPE
—
—
—
-7.50
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
936.02
+1.82%
919.34
+68.26%
546.38
-12.30%
623.04
Current Assets
797.75
+10.69%
720.69
+50.90%
477.59
-12.98%
548.85
Cash Cash Equivalents And Short Term Investments
587.48
-13.75%
681.10
+56.62%
434.88
-7.85%
471.92
Cash And Cash Equivalents
570.12
-16.29%
681.10
+81.18%
375.94
-0.20%
376.69
Other Short Term Investments
17.36
0.00
-100.00%
58.95
-38.10%
95.23
Receivables
139.44
+2853.07%
4.72
+169.67%
1.75
-89.75%
17.08
Accounts Receivable
139.44
+2853.07%
4.72
+169.67%
1.75
—
Other Receivables
—
—
1.75
-89.75%
17.08
Inventory
26.75
0.00
—
—
Prepaid Assets
—
—
—
21.92
Restricted Cash
—
0.13
-99.24%
16.65
-56.10%
37.93
Other Current Assets
44.07
+26.39%
34.87
+43.46%
24.30
+10.87%
21.92
Total Non Current Assets
138.28
-30.39%
198.65
+188.78%
68.79
-7.27%
74.18
Net PPE
13.52
+5.77%
12.78
-35.60%
19.84
-21.40%
25.25
Gross PPE
13.52
+5.77%
12.78
-35.60%
19.84
-21.40%
25.25
Other Properties
13.52
+5.77%
12.78
-35.60%
19.84
-21.40%
25.25
Goodwill And Other Intangible Assets
28.08
+17.35%
23.93
-9.09%
26.32
-8.33%
28.71
Other Intangible Assets
—
—
—
28.71
Investments And Advances
79.97
-44.37%
143.75
0.00
—
Long Term Equity Investment
79.97
-44.37%
143.75
0.00
—
Other Non Current Assets
16.71
-8.15%
18.20
-19.58%
22.62
+11.87%
20.22
Total Liabilities Net Minority Interest
3,012.61
+26.74%
2,376.95
+25.84%
1,888.91
+1.12%
1,867.96
Current Liabilities
287.97
+86.51%
154.40
+7.34%
143.84
+18.46%
121.43
Payables And Accrued Expenses
186.66
+143.00%
76.82
+0.74%
76.25
-2.67%
78.34
Payables
36.23
+276.67%
9.62
-9.73%
10.65
-7.81%
11.56
Accounts Payable
36.23
+276.67%
9.62
-9.73%
10.65
-7.81%
11.56
Current Accrued Expenses
150.44
+123.87%
67.20
+2.45%
65.59
-1.78%
66.78
Pensionand Other Post Retirement Benefit Plans Current
76.70
+31.50%
58.33
+1.67%
57.37
+83.55%
31.26
Current Debt And Capital Lease Obligation
6.19
+37.42%
4.51
+9.16%
4.13
+12.33%
3.67
Current Capital Lease Obligation
6.19
+37.42%
4.51
+9.16%
4.13
+12.33%
3.67
Current Deferred Liabilities
18.41
+24.84%
14.75
+141.93%
6.10
-25.26%
8.16
Current Deferred Revenue
7.19
-50.77%
14.60
+139.57%
6.10
-25.26%
8.16
Total Non Current Liabilities Net Minority Interest
2,724.64
+22.59%
2,222.55
+27.36%
1,745.07
-0.08%
1,746.53
Long Term Debt And Capital Lease Obligation
1,856.28
+7.54%
1,726.08
-0.55%
1,735.71
+0.92%
1,719.89
Long Term Debt
1,852.47
+7.62%
1,721.38
-0.31%
1,726.73
+1.12%
1,707.62
Long Term Capital Lease Obligation
3.81
-18.85%
4.70
-47.71%
8.98
-26.83%
12.27
Non Current Deferred Liabilities
868.11
+74.96%
496.19
+13213.28%
3.73
—
Non Current Deferred Revenue
13.08
-23.49%
17.09
+358.68%
3.73
—
Other Non Current Liabilities
0.24
-14.69%
0.29
-94.92%
5.63
-78.85%
26.64
Stockholders Equity
-2,086.61
-42.15%
-1,467.90
-8.39%
-1,354.26
-7.94%
-1,254.62
Common Stock Equity
-2,086.61
-42.15%
-1,467.90
-8.39%
-1,354.26
-7.94%
-1,254.62
Capital Stock
0.20
+3.06%
0.20
+8.29%
0.18
+15.29%
0.16
Common Stock
0.20
+3.06%
0.20
+8.29%
0.18
+15.29%
0.16
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
202.37
+3.13%
196.24
+8.25%
181.27
+15.60%
156.82
Ordinary Shares Number
194.77
+2.49%
190.04
+8.55%
175.08
+16.24%
150.63
Treasury Shares Number
7.60
+22.70%
6.19
+0.00%
6.19
+0.00%
6.19
Additional Paid In Capital
2,057.65
+8.12%
1,903.15
+28.50%
1,481.03
+57.77%
938.70
Retained Earnings
-3,821.19
-23.41%
-3,096.26
-20.92%
-2,560.50
-33.49%
-1,918.15
Gains Losses Not Affecting Retained Earnings
0.01
+50.00%
0.01
-74.19%
0.03
+109.45%
-0.33
Treasury Stock
323.28
+17.55%
275.00
+0.00%
275.00
+0.00%
275.00
Minority Interest
10.03
-2.56%
10.29
-12.20%
11.72
+20.93%
9.69
Other Equity Adjustments
0.01
+50.00%
0.01
-74.19%
0.03
+109.45%
-0.33
Total Equity Gross Minority Interest
-2,076.58
-42.46%
-1,457.61
-8.57%
-1,342.54
-7.84%
-1,244.92
Total Capitalization
-234.14
-192.37%
253.48
-31.95%
372.47
-17.78%
453.00
Working Capital
509.78
-9.98%
566.29
+69.68%
333.75
-21.92%
427.43
Invested Capital
-234.14
-192.37%
253.48
-31.95%
372.47
-17.78%
453.00
Total Debt
1,862.47
+7.62%
1,730.58
-0.53%
1,739.84
+0.94%
1,723.56
Net Debt
1,282.35
+23.27%
1,040.28
-22.99%
1,350.79
+1.49%
1,330.93
Capital Lease Obligations
10.00
+8.70%
9.20
-29.80%
13.11
-17.81%
15.95
Net Tangible Assets
-2,114.69
-41.75%
-1,491.83
-8.06%
-1,380.58
-7.58%
-1,283.33
Tangible Book Value
-2,114.69
-41.75%
-1,491.83
-8.06%
-1,380.58
-7.58%
-1,283.33
Interest Payable
14.41
+30.35%
11.06
-37.75%
17.76
+1.49%
17.50
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-445.91
+14.37%
-520.73
+1.33%
-527.72
-25.80%
-419.49
Cash Flow From Continuing Operating Activities
-445.91
+14.37%
-520.73
+1.33%
-527.72
-25.80%
-419.49
Net Income From Continuing Operations
-732.94
-34.89%
-543.35
+16.82%
-653.25
-34.79%
-484.65
Depreciation Amortization Depletion
5.43
-10.55%
6.08
-6.45%
6.49
-4.09%
6.77
Depreciation And Amortization
5.43
-10.55%
6.08
-6.45%
6.49
-4.09%
6.77
Other Non Cash Items
136.01
+584.38%
19.87
-14.14%
23.15
+126.17%
-88.45
Stock Based Compensation
133.02
+38.86%
95.80
-11.88%
108.71
+18.73%
91.56
Asset Impairment Charge
—
0.27
0.00
-100.00%
12.72
Operating Gains Losses
84.93
+166.00%
-128.68
-653.73%
-17.07
-217.88%
14.48
Gain Loss On Investment Securities
-8.83
-8.57%
-8.14
+55.57%
-18.31
-322.74%
8.22
Unrealized Gain Loss On Investment Securities
-21.30
-757.26%
-2.48
-209.46%
-0.80
—
Change In Working Capital
-51.06
-259.37%
32.04
+533.62%
5.06
-81.99%
28.08
Change In Receivables
-134.72
-4434.57%
-2.97
-119.38%
15.33
+1.05%
15.17
Changes In Account Receivables
-134.72
-4434.57%
-2.97
-119.38%
15.33
+1.05%
15.17
Change In Inventory
-25.31
0.00
0.00
—
Change In Prepaid Assets
-8.78
+36.94%
-13.92
-415.10%
-2.70
-135.22%
7.67
Change In Payables And Accrued Expense
56.79
+108.59%
27.23
+3645.12%
0.73
+104.93%
-14.75
Change In Accrued Expense
30.18
+17.38%
25.71
+1352.56%
-2.05
+85.74%
-14.40
Change In Payable
26.61
+1659.85%
1.51
-45.61%
2.78
+896.56%
-0.35
Change In Account Payable
26.61
+1659.85%
1.51
-45.61%
2.78
+896.56%
-0.35
Change In Other Working Capital
66.38
+154.69%
26.06
+1456.79%
-1.92
-112.59%
15.26
Change In Other Current Assets
1.11
-27.82%
1.54
+199.74%
-1.55
-114.09%
10.97
Change In Other Current Liabilities
-6.55
-10.93%
-5.90
-22.22%
-4.83
+22.67%
-6.25
Investing Cash Flow
-24.49
-140.29%
60.78
+12.49%
54.03
-88.08%
453.15
Cash Flow From Continuing Investing Activities
-24.49
-140.29%
60.78
+12.49%
54.03
-88.08%
453.15
Net PPE Purchase And Sale
-1.10
-17.58%
-0.93
+28.56%
-1.31
+72.91%
-4.82
Purchase Of PPE
-1.10
-17.58%
-0.93
+28.56%
-1.31
+72.91%
-4.82
Capital Expenditure
-9.59
-7.68%
-8.91
-582.08%
-1.31
+79.34%
-6.32
Net Investment Purchase And Sale
-17.20
-138.95%
44.15
-20.94%
55.84
-83.55%
339.47
Purchase Of Investment
-28.20
+75.28%
-114.08
+16.89%
-137.26
+28.90%
-193.06
Sale Of Investment
11.00
-93.05%
158.23
-18.06%
193.11
-63.74%
532.52
Net Business Purchase And Sale
0.00
+100.00%
-0.14
+72.17%
-0.50
0.00
Purchase Of Business
0.00
+100.00%
-0.14
+72.17%
-0.50
0.00
Gain Loss On Sale Of Business
0.00
+100.00%
-178.32
-14469.14%
1.24
0.00
Net Intangibles Purchase And Sale
-8.49
-6.52%
-7.97
0.00
+100.00%
-1.50
Purchase Of Intangibles
-8.49
-6.52%
-7.97
0.00
+100.00%
-1.50
Net Other Investing Changes
—
—
-0.50
-100.42%
120.00
Financing Cash Flow
359.29
-52.00%
748.46
+65.76%
451.54
+3537.91%
-13.13
Cash Flow From Continuing Financing Activities
359.29
-52.00%
748.46
+65.76%
451.54
+3537.91%
-13.13
Net Issuance Payments Of Debt
116.00
+595.37%
-23.42
0.00
+100.00%
-20.49
Issuance Of Debt
575.00
+27.78%
450.00
0.00
0.00
Repayment Of Debt
-459.00
+3.05%
-473.42
0.00
+100.00%
-20.49
Long Term Debt Issuance
575.00
+27.78%
450.00
0.00
0.00
Long Term Debt Payments
-459.00
+3.05%
-473.42
0.00
+100.00%
-20.49
Net Long Term Debt Issuance
116.00
+595.37%
-23.42
0.00
+100.00%
-20.49
Net Common Stock Issuance
-62.50
-120.34%
307.21
-30.64%
442.93
+13358.83%
3.29
Common Stock Payments
-62.50
-730.48%
-7.53
-9.39%
-6.88
-340.74%
-1.56
Repurchase Of Capital Stock
-62.50
-730.48%
-7.53
-9.39%
-6.88
-340.74%
-1.56
Proceeds From Stock Option Exercised
34.15
+318.60%
8.16
-13.27%
9.41
+191.75%
3.22
Net Other Financing Charges
271.65
-40.49%
456.50
+57091.39%
-0.80
-195.70%
0.84
Changes In Cash
-111.10
-138.51%
288.51
+1402.42%
-22.15
-207.96%
20.52
Beginning Cash Position
683.24
+73.09%
394.73
-5.31%
416.88
+5.18%
396.37
End Cash Position
572.14
-16.26%
683.24
+73.09%
394.73
-5.31%
416.88
Free Cash Flow
-455.50
+14.00%
-529.63
-0.11%
-529.03
-24.24%
-425.81
Interest Paid Supplemental Data
43.76
-52.09%
91.34
+49.48%
61.11
+12.24%
54.44
Income Tax Paid Supplemental Data
1.20
—
—
—
Common Stock Issuance
0.00
-100.00%
314.74
-30.03%
449.81
+9170.61%
4.85
Dividends Received CFI
2.30
-91.04%
25.68
0.00
0.00
Earnings Losses From Equity Investments
72.61
+132.84%
31.18
0.00
0.00
Issuance Of Capital Stock
0.00
-100.00%
314.74
-30.03%
449.81
+9170.61%
4.85
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category